$23.54
+0.41 (+1.77%)
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Price Target
Analyst Price Target
-24.1% upside
Low Target
$12.55
Average Target
$17.86
High Target
$20.90
Current Price
$23.54
Current
$23.54
$23.54
Target
$17.86
$17.86
$12.55
$17.86 avg
$20.90
Scenario Analysis
Bear Case
$12.55
-46.7%
Low target
Base Case
$17.86
-24.1%
Avg target
Bull Case
$20.90
+-11.2%
High target
Risk/Reward
0.2x
Unfavorable
Price in Context
52-Week High
$29.75
-20.9% from high
52-Week Low
$11.51
+104.5% from low
Target vs 52W High
$17.86
-40.0% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | +4.7% |
| AMGN | Hold | 43 | 49% | $190.87 | -53.6% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +172.3% |
| VRTX | Strong Buy | 37 | 81% | $438.34 | -11.6% |
| REGN | Buy | 37 | 70% | $76.80 | -90.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -55.6% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -44.4% |
| BIIB | Buy | 43 | 67% | $91.45 | -56.0% |